期刊文献+

EAC方案治疗22例晚期胃癌临床观察 被引量:1

Etoposide,Adriamycin and Carboplatin(EAC) Combination Chemotherapy for Advanced Gastric Cancer in 22 Cases
下载PDF
导出
摘要 本文报道采用鬼臼乙叉甙、阿霉素和卡铂联合方案治疗晚期胃癌22例。缓解率为45.45%,其中完全缓解率9.09%(2/22),部分缓解率36.36%(8/22)。主要毒副反应为轻到中度骨髓抑制、脱发和轻度恶心、呕吐。本方案与相似的含顺铂的EAP方案相比,消化道反应明显减轻,骨髓抑制相同,缓解率近似。 This article reports 22 cases of advanced gastric cancers treated by the combined chemotherapy of Etoposide,Adriamycin and Carboplatin.The total remission rate is 45.45%,including 9.09% (2/22) of complete remission and 36.36% (8/22) of partial remission respectively.The main toxic reactions are mild to moderate myelosuppression and alopecia,mild nausea and vomiting.In comparison with EAP regimen,nausea and vomiting of EAC regimen is mild with low occurrence,the myelosuppressions are the same,and the remission rates are similar.
出处 《河南肿瘤学杂志》 1995年第1期39-41,共3页 Henan Journal of Oncology
关键词 晚期 胃肿瘤 缓解率 药物疗法 advanced gastric cancer chemotherapy remission rate
  • 相关文献

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部